- Home
- FTV vs WST Comparison
FTV vs WST Comparison
Compare FTV & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTV
- WST
- Stock Information
- Founded
- FTV 2015
- WST 1923
- Country
- FTV United States
- WST United States
- Employees
- FTV N/A
- WST N/A
- Industry
- FTV Industrial Machinery/Components
- WST Medical/Dental Instruments
- Sector
- FTV Industrials
- WST Health Care
- Exchange
- FTV Nasdaq
- WST Nasdaq
- Market Cap
- FTV 23.9B
- WST 20.1B
- IPO Year
- FTV N/A
- WST N/A
- Fundamental
- Price
- FTV $49.63
- WST $306.39
- Analyst Decision
- FTV Hold
- WST Strong Buy
- Analyst Count
- FTV 13
- WST 8
- Target Price
- FTV $60.58
- WST $339.43
- AVG Volume (30 Days)
- FTV 2.3M
- WST 695.6K
- Earning Date
- FTV 10-29-2025
- WST 10-23-2025
- Dividend Yield
- FTV 0.48%
- WST 0.29%
- EPS Growth
- FTV N/A
- WST N/A
- EPS
- FTV 2.22
- WST 6.68
- Revenue
- FTV $6,147,900,000.00
- WST $2,960,200,000.00
- Revenue This Year
- FTV N/A
- WST $6.49
- Revenue Next Year
- FTV $3.37
- WST $6.23
- P/E Ratio
- FTV $22.32
- WST $45.96
- Revenue Growth
- FTV N/A
- WST 2.90
- 52 Week Low
- FTV $45.51
- WST $187.43
- 52 Week High
- FTV $62.79
- WST $352.33
- Technical
- Relative Strength Index (RSI)
- FTV 53.73
- WST 80.65
- Support Level
- FTV $47.95
- WST $260.12
- Resistance Level
- FTV $50.16
- WST $265.66
- Average True Range (ATR)
- FTV 0.99
- WST 6.80
- MACD
- FTV 0.06
- WST 2.75
- Stochastic Oscillator
- FTV 61.50
- WST 75.40
About FTV Fortive Corporation
Fortive is a diversified industrial technology firm with a broad portfolio of mission-critical products and services that include field solutions, product realization, health, and sensing technologies. The company serves a wide range of end markets, including manufacturing, utilities, medical, and electronics. Fortive generated roughly $6.2 billion in revenue in 2024.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.